ipilimumab
bms
['melanoma']
 it s the first time that we ve had a result like that with a cell therapy immunotherapy for patients with melanoma, says our dr. michael davies of clinical trial results presented at #esmo22: #melanoma #endcancer
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789